| Literature DB >> 28553645 |
Hongyang Jiang1, Zhe Yu1, Liping Chen1, Tao Wang1, Zhuo Liu1, Jihong Liu1, Shaogang Wang1, Zhangqun Ye1.
Abstract
Minimally invasive percutaneous nephrolithotomy (mini-PCNL) and retrograde intrarenal surgery (RIRS) are both alternatives for PCNL to treat renal calculi. This study is aimed at comparing the stone-free rate (SFR) and other surgery parameters of two approaches for treating upper urinary calculi. We performed this meta-analysis in September 2016 by searching studies about mini-PCNL and RIRS for treating upper urinary calculi in various databases, and RevMan v.5.3 was applied. Three randomized controlled trials and ten nonrandomized trials were included, involving a total of 1317 patients. Meta-analysis showed that mini-PCNL group led to a higher SFR [odds ratio: 1.96; 95% confidence interval: 1.46-2.64; P < 0.00001] but brought a larger postoperative decrease in hemoglobin levels compared with RIRS. RIRS provided a shorter hospital time. There was no significant difference in operation time. Higher postoperative complications were detected in the mini-PCNL, but the difference was not significant. Grade I and III complications did not vary between two procedures, but grade II complications were of lower incidence in RIRS group. In the light of these results, compared with RIRS, mini-PCNL provided significantly higher SFR and efficiency quotient for managing calculi; however, it resulted in higher incidence of postoperative complications, larger hemoglobin drops, and longer hospital stay.Entities:
Mesh:
Year: 2017 PMID: 28553645 PMCID: PMC5434463 DOI: 10.1155/2017/2035851
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Summary of included studies.
| Study | Institution (country) | Study period | Study design | LE | Inclusion criteria | Cases, | Study quality | |
|---|---|---|---|---|---|---|---|---|
| mPCNL | RIRS | |||||||
| Lee et al. [ | Dongguk University Ilsan Hospital (South Korea) | 2014-2015 | RCT | 2b | >1 cm, single or multiple renal stones | 35 | 33 | 3 |
| Ozgor et al. [ | Haseki Teaching and Research Hospital (Turkey) | 2012–2015 | Retrospective case control | 3b | 1-2 cm, BMI > 30 kg/m2, any location | 56 | 56 | 7# |
| Wilhelm et al. [ | University Medical Centre Freiburg (Germany) | 2013-2014 | Matched-pair analysis | 3b | 1–3.5 cm | 25 | 25 | 5# |
| Pan et al. [ | Renji Hospital (China) | 2005–2011 | Prospective case control | 3b | 2-3 cm, single stone, any location | 59 | 56 | 6# |
| Kirac et al. [ | Koru Hospital (Turkey) | 2009–2012 | Retrospective case control | 3b | <1.5 cm, lower pole | 37 | 36 | 6# |
| Kumar et al. [ | V.M. Medical College and Safdarjung Hospital (India) | 2012-2013 | RCT | 2b | 1-2 cm, single stone, lower pole | 41 | 43 | 3 |
| Sabnis et al. [ | Muljibhai Patel Urological Hospital (India) | 2009–2011 | Prospective case control | 3b | 1-2 cm, single or multiple stones, any location | 32 | 32 | 6# |
| Kruck et al. [ | Multiple institutions (Germany) | 2001–2007 | Retrospective case control | 3b | Any size, any location | 172 | 108 | 4# |
| Hu et al. [ | Tongji Hospital (China) | 2010–2015 | Retrospective case control | 3b | 1-2 cm, any location, older than 60 years old | 104 | 80 | 6# |
| Zeng et al. [ | The First Affiliated Hospital of Guangzhou Medical University (China) | 2012–2014 | Matched-pair analysis | 3b | >2 cm, any location, solitary kidney | 53 | 53 | 7# |
| Zhang et al. [ | Wu Jieping Urology Center (China) | 2010–2012 | Prospective case control | 3b | 1-2 cm, single stone, proximal ureter | 32 | 44 | 6# |
| Gu et al. [ | Jiangsu Province Hospital (China) | 2010-2011 | RCT | 2b | ≥1.5 cm, proximal ureter | 30 | 29 | 3 |
| Knoll et al. [ | Klinikum Sindelfingen-Boeblingen Medical Center (Germany) | 2008–2010 | Prospective case control | 3b | 1–3 cm, solitary renal calculi, any location | 25 | 21 | 6# |
LE = level of evidence; mPCNL = minimally invasive PCNL; RIRS = retrograde intrarenal surgery, RCT = randomized controlled trials.
#Using Newcastle–Ottawa Scale (score from 0 to 9).
Using Jadad scale (score from 0 to 5).
Figure 1Study flow chart.
Characters of patients and calculus.
| Study | Treatment | Age (year) | Male/Female | BMI (kg/m2) | Stone size (mm) | Stone location (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Upper pole | Middle pole | Lower pole | Renal pelvis | Proximal ureter | Multiple | ||||||
| Lee et al. [ | Mini-PCNL | 59.3 ± 13.3 | 28/7 | 26.3 ± 3.9 | 39.1 ± 30.7 | 2.9 | — | 40.0 | 17.1 | — | 40.0 |
| RIRS | 55.8 ± 11.2 | 28/5 | 25.6 ± 5.1 | 28.9 ± 17.5 | 3.0 | — | 30.3 | 27.3 | — | 39.4 | |
| Ozgor et al. [ | Mini-PCNL | 51.4 ± 14.3 | 25/31 | 34.0 ± 3.3 | 19.5 ± 3.9 | 8.9 | 1.8 | 26.8 | 25.0 | — | 37.5 |
| RIRS | 54.2 ± 10.6 | 22/34 | 34.4 ± 5.0 | 18.3 ± 3.2 | 7.1 | 1.8 | 26.8 | 39.3 | — | 25.0 | |
| Wilhelm et al. [ | Mini-PCNL | 51.56 (15–75) | 15/10 | 29.54 (18.75–42.94) | 19.3 (10–35) | — | — | — | — | — | — |
| RIRS | 51.36 (19–77) | 19/6 | 28.41 (18.4–38.57) | 19.2 (10–35) | — | — | — | — | — | — | |
| Pan et al. [ | Mini-PCNL | 49.37 ± 14.2 | 37/22 | 23.52 ± 3.7 | 22.37 ± 2.7 | 8.5 | 18.6 | 52.5 | 20.3 | — | — |
| RIRS | 49.32 ± 13.7 | 36/20 | 23.69 ± 3.6 | 22.28 ± 2.6 | 12.5 | 12.5 | 51.8 | 23.2 | — | — | |
| Kirac et al. [ | Mini-PCNL | 41.02 ± 10.3 | 25/12 | 18.5 ± 4.9 | 10.5 ± 2.2 | — | — | 100 | — | — | — |
| RIRS | 37.8 ± 8.7 | 22/14 | 18.3 ± 5.0 | 10.2 ± 2.9 | — | — | 100 | — | — | — | |
| Kumar et al. [ | Mini-PCNL | 33.7 ± 1.6 | 20/21 | 23.5 ± 1.2 | 13.3 ± 1.3 | — | — | — | — | — | — |
| RIRS | 33.4 ± 1.4 | 20/23 | 23.6 ± 1.1 | 13.1 ± 1.1 | — | — | — | — | — | — | |
| Sabnis et al. [ | Mini-PCNL | 44.48 ± 12.36 | 19/13 | — | 15.2 ± 3.3 | 3.1 | 0.0 | 31.3 | 43.8 | — | 21.9 |
| RIRS | 49.28 ± 12.19 | 25/7 | — | 14.2 ± 3.4 | 9.4 | 3.1 | 28.1 | 25.0 | — | 34.4 | |
| Kruck et al. [ | Mini-PCNL | 53.3 ± 14.8 | 109/63 | — | 12.6 ± 9.5 | — | — | 42.7 | — | — | — |
| RIRS | 50 ± 16.7 | 69/39 | — | 6.8 ± 6.9 | — | — | 76.8 | — | — | — | |
| Hu et al. [ | Mini-PCNL | 65.5 ± 4.9 | 56/48 | 23.7 ± 3.5 | 15.8 ± 3.4 | 1.9 | 7.7 | 13.5 | 40.4 | 36.5 | 59.6 |
| RIRS | 65.1 ± 5.2 | 45/35 | 23.0 ± 3.1 | 15.8 ± 3.4 | 3.8 | 12.5 | 17.5 | 37.5 | 28.8 | 57.5 | |
| Zeng et al. [ | Mini-PCNL | 53.04 ± 14.09 | 36/17 | 23.26 ± 3.41 | 329.34 ± 184.27 | 3.8 | 3.8 | 22.6 | 22.6 | — | 47.2 |
| RIRS | 48.47 ± 11.96 | 39/14 | 23.63 ± 3.83 | 331.87 ± 182.55 | 5.7 | 3.8 | 18.9 | 26.4 | — | 45.3 | |
| Zhang et al. [ | Mini-PCNL | 42.7 ± 13.6 | 24/8 | — | 15.6 ± 2.5 | — | — | — | — | 100 | — |
| RIRS | 43.3 ± 11 | 29/15 | — | 14.9 ± 2.3 | — | — | — | — | 100 | — | |
| Gu et al. [ | Mini-PCNL | 42.5 ± 10.1 | — | — | 17.27 (15–25) | — | — | — | — | 100 | — |
| RIRS | 44.22 ± 13 | — | — | 16.23 (15–25) | — | — | — | — | 100 | — | |
| Knoll et al. [ | Mini-PCNL | 56 ± 13 | 15/10 | 27 ± 5 | 18 ± 5 | 4.0 | 68.0 | 12.0 | 56.0 | — | — |
| RIRS | 53 ± 11 | 9/12 | 31 ± 7 | 19 ± 4 | 9.5 | 66.7 | 4.8 | 38.1 | — | — | |
Note. Mini-PCNL = minimally invasive percutaneous nephrolithotomy; RIRS = retrograde intrarenal surgery; Unit = mm2; all other units are in millimeters.
The characters of the surgical methods of included studies.
| Study | Treatment | Access sheath size, Fr | Dilator | Nephroscope size | Lithotripsy |
|---|---|---|---|---|---|
| Lee et al. [ | Mini-PCNL | 18 | Balloon | 15 F | Laser |
| RIRS | 14/16 | UAS | 7.5 F | Laser | |
| Ozgor et al. [ | Mini-PCNL | 18 or 20 | Amplatz | 17 F | Laser and ultrasound |
| RIRS | 19/23 | UAS | 7.5 F | Laser | |
| Wilhelm et al. [ | Mini-PCNL | 10 and 14 | PTFE dilators/Amplatz | 13 F | Laser |
| RIRS | 7/8 | UAS | — | Laser | |
| Pan et al. [ | Mini-PCNL | 18 | Amplatz | 14 F | Laser |
| RIRS | 12 | UAS | Olympus P3 or P5 | Laser | |
| Kirac et al. [ | Mini-PCNL | 20 | Amplatz | 15–16.5 F | Pneumatic or ultrasound energy |
| RIRS | 9.5/11.5 or 12/14 | UAS | 8 or 9.5 F, | Laser | |
| Kumar et al. [ | Mini-PCNL | 18 | gauge needle | 15 F | Pneumatic |
| RIRS | 12 | UAS | 8/9.8 F | Laser | |
| Sabnis et al. [ | Mini-PCNL | 16–19 | 22-gauge Skinny Needle | 15/18 F and 16.5/19.5 F | Laser |
| RIRS | 14 | UAS | 7.5-F Flex X–2 | Laser | |
| Kruck et al. [ | Mini-PCNL | 16–18 | Metal | 12 F | Ultrasound |
| RIRS | — | Fascial dilator | Flex-X/Flex-X2 | Laser | |
| Hu et al. [ | mPCNL | 16–20 | Fascial dilator | 8/9.8 F | Laser |
| RIRS | 12/14 | UAS | Flex-X2 | Laser | |
| Zeng et al. [ | Mini-PCNL | 18 | Fascial dilators | — | Laser and pneumatic |
| RIRS | 12/14 | UAS | 7.5 F | Laser | |
| Zhang et al. [ | Mini-PCNL | 18–20 | facial dilators | 8.6/9.8 F | Laser and pneumatic |
| RIRS | 12/14 | UAS | 5.3–8.4 F | Laser | |
| Gu et al. [ | Mini-PCNL | 12/18 | Fascial dilators | 8.5/9.8 F | Laser |
| RIRS | — | UAS | 7.4 F | Laser | |
| Knoll et al. [ | Mini-PCNL | 18 | Amplatz | 14 F | Laser |
| RIRS | 12/14 | — | — | Laser |
Mini-PCNL = minimally invasive percutaneous nephrolithotomy; RIRS = retrograde intrarenal surgery; UAS = ureteral access sheath placement.
Figure 2Forest plot and meta-analysis of stone-free rate in renal stone patients.
Figure 3Forest plot and meta-analysis of location subgroup of stone-free rate.
Figure 4Forest plot and meta-analysis of stone size subgroup of stone-free rate.
Figure 5Forest plot and meta-analysis of outcomes in renal stone patients: (a) operative time; (b) hospital stay; (c) hemoglobin drop.
Figure 6Forest plot and meta-analysis of total complications for two procedures.
Clavien-Dindo Classification for surgical complication.
| Surgical complications classification | Description | For example |
|---|---|---|
| Grade I | Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions. | Bleeding, pain, fever, vomiting, tachycardia, hyperkalemia, and so forth. |
| Grade II | Requiring pharmacological treatment with drugs other than such allowed for grade I complications. | Minor pelvic/ureter perforation, hypertension requiring nicardipine, urinary tract infection, subcapsular hematoma, and so forth. |
| Grade III | Requiring surgical, endoscopic, or radiological intervention. | Embolization, steinstrasse, and so forth. |
| Grade IV | Life-threatening complication (including CNS complications)‡ requiring IC/ICU-management | Shock and so forth. |
| Grade V | Death of a patient. | Death and so forth. |
Figure 7Forest plot and meta-analyses of postoperative complications.
Sensitivity analysis results.
| Items | Studies | Sample size | Tests for heterogeneity | Analysis model | Test for overall effect | RR/WMD 95% CI | Favors | ||
|---|---|---|---|---|---|---|---|---|---|
| Mini-PCNL/RIRS |
|
|
|
| |||||
| Stone-free rate | [ | 215/214 | 51% | 0.09 | Fixed | 2.52 | 0.01 | 1.92 [1.16, 3.18] | Mini-PCNL |
| Operative time | [ | 215/214 | 94% | <0.00001 | Random | 1.06 | 0.29 | 7.60 [−5.32, 20.53] | RIRS |
| Hemoglobin drop | [ | 88/86 | 0 | 0.60 | Random | 1.55 | 0.12 | 0.21 [−0.06, 0.47] | RIRS |
| Hospital stay | [ | 121/118 | 94% | <0.00001 | Random | 1.99 | 0.05 | 1.34 [0.02, 2.67] | RIRS |
| Total complication | [ | 185/185 | 84% | 0.00003 | Random | 0.44 | 0.66 | 1.38 [0.33, 5.84] | RIRS |
| Grade I | [ | 185/185 | 78% | 0.04 | Random | 0.44 | 0.66 | 1.35 [0.35, 5.15] | RIRS |
| Grade II | [ | 185/185 | 0 | 0.65 | Random | 0.46 | 0.64 | 1.22 [0.52, 2.86] | RIRS |
| Grade III | [ | 109/109 | 35% | 0.21 | Random | 0.94 | 0.35 | 3.36 [0.27, 41.48] | RIRS |
Mini-PCNL: minimally invasive percutaneous nephrolithotomy; RIRS: retrograde intrarenal surgery; RR: relative risk; WMD: weighted mean difference; CI: confidence interval.
Figure 8Funnel plot for the publication bias test of mini-PCNL versus RIRS.
Efficiency quotient in included studies.
| Study | EQ for mini-PCNL | EQ for RIRS |
|
|---|---|---|---|
| Pan et al. [ | 0.904 | 0.523 | — |
| Kumar et al. [ | 0.915 | 0.842 | 0.01 |
| Gu et al. [ | 0.830 | 0.500 | — |
EQ = efficiency quotient.